Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans

被引:102
作者
Cheng, Fei [1 ,2 ]
Wang, Yan [1 ]
Li, Jing [1 ]
Su, Chen [1 ]
Wu, Fang [1 ]
Xia, Wen-Hao [1 ]
Yang, Zhen [1 ]
Yu, Bing-Bo [1 ]
Qiu, Yan-Xia [1 ]
Tao, Jun [1 ]
机构
[1] Sun Yat Sen Univ, Dept Hypertens & Vasc Dis, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China
[2] Dongguan Shilong Peoples Hosp, Dept Cardiol, Dongguan 523321, Peoples R China
关键词
Endothelial microparticles; Berberine; Oxidative stress; Endothelial function; Nitric oxide; NITRIC-OXIDE PRODUCTION; PULSE-WAVE ANALYSIS; IN-VITRO; ARTERIAL ELASTICITY; NADH/NADPH OXIDASE; PROGENITOR CELLS; NADPH OXIDASE; DYSFUNCTION; CORRELATE; GENERATION;
D O I
10.1016/j.ijcard.2012.03.090
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Circulating endothelial microparticles (EMPs) lead to endothelial dysfunction by increasing oxidative stress. Berberine has a beneficial effect on endothelial function, but no data are available on the EMP-mediated oxidative stress. The present study tests the hypothesis that berberine contributes to the improvement of endothelial function in humans via inhibiting EMP-mediated oxidative stress in vascular endothelium. Methods: Twelve healthy subjects received a 1-month berberine therapy and eleven healthy subjects served as control. Endothelium-dependent and -independent function in the brachial artery was assessed by flow-mediated vasodilation (FMD) and sublingual nitroglyceride-mediated vasodilation (NMD). Circulating EMPs and serum malondialdehyde (MDA) were measured before and after therapy. Furthermore, in vitro human umbilical vein endothelial cells (HUVECs) were stimulated by EMPs with or without presence of anti-oxidant compound apocynin or berberine. Intracellular reactive oxygen species (ROS), nitric oxide (NO) production and NADPH oxidase 4 (Nox4) protein expressions were examined, respectively. Results: The levels of serum MDA and circulating CD31+/CD42- MPs were significantly reduced in the berberine group compared with the control group, which were associated with improvement of FMD. The EMPs in vitro facilitated ROS production and Nox4 protein expression and reduced NO synthesis in HUVECs. These alterations can be reversed by the presence of apocynin or berberine, respectively. Conclusion: The present study demonstrated for the first time that EMP-induced upregulation of Nox4 expression may enhance ROS production in HUVECs. Berberine treatment contributes to the amelioration of endothelial function through a partially reducing oxidative stress of vascular endothelium induced by circulating CD31+/CD42- microparticles in humans. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:936 / 942
页数:7
相关论文
共 40 条
[1]
Cardiovascular and metabolic effects of Berberine [J].
Affuso, Flora ;
Mercurio, Valentina ;
Fazio, Valeria ;
Fazio, Serafino .
WORLD JOURNAL OF CARDIOLOGY, 2010, 2 (04) :71-77
[2]
Enclothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome [J].
Agouni, Abdelali ;
Lagrue-Lak-Hal, Anne Helene ;
Ducluzeau, Pierre Henri ;
Mostefai, Hadj Ahmed ;
Draunet-Busson, Catherine ;
Leftheriotis, Georges ;
Heymes, Christophe ;
Martinez, Maria Carmen ;
Andriantsitohaina, Ramaroson .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (04) :1210-1219
[3]
Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure [J].
Amabile, N ;
Guérin, AP ;
Leroyer, A ;
Mallat, Z ;
Nguyen, C ;
Boddaert, J ;
London, GM ;
Tedgui, A ;
Boulanger, CM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11) :3381-3388
[4]
High levels of circulating endothelial microparticles in patients with acute coronary syndromes [J].
Bernal-Mizrachi, L ;
Jy, W ;
Jimenez, JJ ;
Pastor, J ;
Mauro, LM ;
Horstman, LL ;
de Marchena, E ;
Ahn, YS .
AMERICAN HEART JOURNAL, 2003, 145 (06) :962-970
[5]
Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes [J].
Bernal-Mizrachi, L ;
Jy, W ;
Fierro, C ;
Macdonough, R ;
Velazques, HA ;
Purow, J ;
Jimenez, JJ ;
Horstman, LL ;
Ferreira, A ;
de Marchena, E ;
Ahn, YS .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 (03) :439-446
[6]
Endothelium-derived microparticles impair endothelial function in vitro [J].
Brodsky, SV ;
Zhang, F ;
Nasjletti, A ;
Goligorsky, MS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (05) :H1910-H1915
[7]
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension [J].
Brunner, H ;
Cockcroft, JR ;
Deanfield, J ;
Donald, A ;
Ferrannini, E ;
Halcox, J ;
Kiowski, W ;
Luscher, TF ;
Mancia, G ;
Natali, A ;
Oliver, JJ ;
Pessina, AC ;
Rizzoni, D ;
Rossi, GP ;
Salvetti, A ;
Spieker, LE ;
Taddei, S ;
Webb, DJ .
JOURNAL OF HYPERTENSION, 2005, 23 (02) :233-246
[8]
Circulating endothelial microparticles correlate inversely with endotheilal function in patients with ischemic left ventricular dysfunction [J].
Bulut, Daniel ;
Maier, Karin ;
Bulut-Streich, Nadine ;
Boergel, Jan ;
Hanefeld, Christoph ;
Muegge, Andreas .
JOURNAL OF CARDIAC FAILURE, 2008, 14 (04) :336-340
[9]
Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844
[10]
Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers [J].
Carroll, MF ;
Schade, DS .
CIRCULATION, 2003, 108 (01) :24-31